<DOC>
	<DOCNO>NCT00835107</DOCNO>
	<brief_summary>This study use polysomnographs ( PSG ) investigate sleep pattern patient bipolar depression . This double-blind , placebo-controlled , study ziprasidone added patient current medication . The objective relate change slow wave rapid eye movement sleep change mood overall illness severity . Participants randomly assign add either placebo ziprasidone current treatment regimen . Participants make 3 4 study visit , 1 month period , ask history , mood sleep quality . Participants also three in-home overnight polysomnographs .</brief_summary>
	<brief_title>An Investigation Sleep Architecture Ziprasidone-Treated Bipolar Depression</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Ziprasidone</mesh_term>
	<criteria>A diagnosis Bipolar Disorder Type 1,2 NOS Diagnostic Statistical Manual Mental Disorders Fourth Edition ( DSMIV ) . Current depressive episode HAMD17 &gt; 16 . Males Females age 18yrs . Inpatients outpatient . Female patient childbearing potential must use reliable method contraception negative urine human chorionic gonadotropin ( HCG ) test enrolment . Able understand comply requirement study . Provision write informed consent . Current Manic , Hypomanic Mixed episode , YMRS &gt; 12 . Current past diagnosis Schizophrenia Dementia . Pregnant woman , woman childbearing age , willing use appropriate contraception woman currently nurse . Patient antipsychotic medication . Patients , opinion investigator , pose imminent risk suicide danger self others . Known intolerance lack response Ziprasidone , judge investigator . Benzodiazepines sleepaids must discontinue prior participation study stable dosage 4 week previous entry study . No change current medication regime ( exclude discontinuation sleep aid antipsychotic medication ) allow 4 week prior first PSG reading . Administration depot antipsychotic injection within two dose interval ( depot ) randomization . Substance alcohol dependence enrolment last three month ( except caffeine nicotine dependence ) , define DSMIV criterion . Serious , unstable inadequately treat medical illness judge investigator . History epilepsy uncontrolled seizure . Involvement plan conduct study . Previous enrolment present study . Participation another drug trial within 4 week prior enrolment study long accordance local requirement . Patients serum potassium , magnesium and/or calcium level outside normal range baseline . Patients mark liver function abnormality baseline , demonstrate laboratory value , judgment investigator . Known serological evidence HIV , acute chronic hepatitis ; donation blood blood product transfusion prior initiation treatment study drug , study 30 day study end . Known history QT prolongation ( include congenital long QT syndrome ) . Recent acute myocardial infarction uncompensated heart failure . Currently take drug know prolong QT interval .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Bipolar Depression</keyword>
	<keyword>Sleep</keyword>
	<keyword>Polysomnograph</keyword>
	<keyword>Slow Wave Sleep</keyword>
	<keyword>Ziprasidone</keyword>
	<keyword>Antipsychotic</keyword>
	<keyword>Placebo</keyword>
</DOC>